Novilase is a minimally invasive procedure that uses laser ablation to destroy tumors. Novilase was cleared by the FDA for the treatment of benign breast tumors. Novilase is currently being evaluated in multi-center international clinical trials as a treatment for small breast cancers.

Novilase laser ablation provides an alternative to surgery while preserving options for additional procedures or adjuvant therapies. The outpatient Novilase procedure does not require general anesthesia or a hospital stay. Therapy consists of ultrasound or x-ray image-guided placement of two small probes (one to deliver laser energy and the second to monitor temperature at the edge of the ablation zone) by a trained physician into the tumor site after local anesthetic.